DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing

Area of Science:

• Immunology
• Oncology
• Transplantation

Background:

• Damage-associated molecular patterns (DAMPs) are released from dying cells.
• DAMPs are implicated in allograft rejection following ischemia-reperfusion injury.
• DAMPs also play a crucial role in the success of cancer immunotherapy.

Purpose of the Study:

• To review the literature on the pathophysiological importance of DAMP release.
• To discuss the implications of DAMP release in allograft rejection and cancer immunotherapy.
• To highlight the mechanistic overlap between these two fields.

Main Methods:

• Literature review of recent studies on DAMPs.
• Analysis of DAMPs' role in cell death, inflammation, and immune responses.
• Comparative analysis of DAMPs' impact on transplantation and cancer immunotherapy.

Main Results:

• DAMP release is a key factor in allograft rejection.
• DAMPs act as potent triggers for anti-tumor immune responses.
• A significant mechanistic overlap exists between DAMPs in rejection and immunotherapy.

Conclusions:

• Regulated necrosis and inflammation provide a common mechanistic basis for allograft rejection and cancer immunotherapy.
• Understanding DAMPs' molecular characterization can benefit both transplant and oncology fields.
• Targeting DAMP-mediated pathways may offer novel therapeutic strategies.